Capricor Therapeutics Inc News - CAPR

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Form 8-K - Current report

Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy

--FDA assigns PDUFA target action date of August 31, 2025-- --If approved, deramiocel would be first therapy to...

Form 4 - Statement of changes in beneficial ownership of securities

Capricor Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

GreedyAgorist 3 weeks ago

Wow, I hardly ever perfectly time the bottom, but I sold a cash covered put today when it was red, and before I could second guess my play, it was green and up more than two bucks.

Any explanation for the 12% gain?

Oh, well, we were here ten days ago. Nothing to get excited about, right?

👍️0

Mr.Mister 1 month ago

With BLA submission in late December, when would the FDA have to accept or reject their application by? Late February?

👍️0

Volcano 1 month ago

Breaking out now
Get ready for $70 upon FDA approval

💯 1 🔥 1

Volcano 2 months ago

Price target $70-$100 upon FDA approval in a few months
Multi millionaire soon to be

👍 1

XWAVXALMIMAN 2 months ago

We got the news. We finished the submission and got $10 million. People are so impatient. I’ve waited 4 1/2 years. I can wait 6-9 months for approval. Families and patients should be pushing for a much quicker approval. 30-40 in 2025.

MomsSpaghetti 2 months ago

My question to you CAPR folks who are likely more versed than I. Is after the submission is sent to FDA for approval (in your case Deramiocel (CAP-1002)) - How long does it take FDA to make a decision on average?

I am following another company MNMD that is in Phase 3 right now for LSD that got FDA Break Through Designation.

👍️0

GreedyAgorist 2 months ago

Guess I was wrong about the new 5. It is not 20 or 17.50. Not yet. Those were the pump prices. If the pump is over for now, we might hang out around 12.50 for a while, making puts at 12.50 and 10 interesting. Likewise calls at 15 might be worth a shot. Although my next play is targeting March 17.50. If it gets there early, that will inform my next move.

👍️0

XWAVXALMIMAN 3 months ago

You’ll be sorry. Definitely an easy double from here within a year. I’ve held most shares for 4 1/2 years. Be patient. Linda sounded great - listened to interview last night after 12 days in Puerto Vallarta

👍️ 1

Laster 3 months ago

Got out yesterday afternoon before that huge dump.
It looked like it wanted to drop below $16.
Crazy AH trading down to $11 and back to $16.
Concern about one of their investigators.
Either way, I am out and hope others can make a better trade than I did. Now moving my money to other more quality stocks. JMO.

👍️0

D-bol 3 months ago

What a day. Still not selling.

👍️0

PonkenPlonken 3 months ago

RFK is irrelevant to how CAPR moves.

Everything is in the price here... plus a lot of birds in the bush. Why anyone would hold this stock AFTER it all happened, no catalyst on the horizeon. Presentation roadmap ends at "today".... is clear indication they know nothing will happen for a good year or two. So it will need a breather - which I believe you see in the chart.

Bios run towards events - not because of them.
GL

👍️0

Laster 3 months ago

Thank you. I have patience and can wait for mid 2025.
The problem is the biotech sector. It has gotten destroyed since Trump picked RFK Jr. as HHS secretary. Hopefully it will recover if RFK Jr. somehow doesn’t get the job.
Just hate the BS manipulation to drop stocks on no news. The stock market is a joke. Many Stocks now move on no news. I have seen stocks move from $1 to $10 on nothing. How is that possible or legal?
Just hope it doesn’t drop lower than $15. Then I might have to throw in the towel and move on.

👍️0

PonkenPlonken 3 months ago

This stock trades on a lot of hopes, dreams and "ifs".
Not unlikely that whatever they announce, it will be a sell on news event.
It believe it has to cool off until the PDUFA which is ca 1 year away.
When the roadmap a company gives in their presentation ends with "today"...... is usually not a good sign. That is speaking in terms of PPS. For the company, everything is well and funding wont be an issue.

👍️0

Laster 3 months ago

Now down to $17.50. WOW. I can only guess people were expecting news on the BLA submission.
Maybe they are getting financing through the ATM and selling into the market.
Either way, this doesn't look good today.

👍️0

Laster 3 months ago

This stock is ridiculous. I don't know if it is manipulation or MMs getting the stop losses?
Opened at $19.44 and then in 1 minute it went to $20.75 and then the next minute it is down to $18.92.
Clearly, someone continues to keep this below $20. When will they be done????
This is criminal IMO. I am holding because I think it makes a run to $30 once all this crap is over.
MACD histogram on the daily is going to turn positive today.
JMO.

👍️0

Laster 3 months ago

The stock chart looks interesting. The MACD histogram is ready to turn positive.
The stock found support at the 25 day moving average.
PnF chart clearly shows double/triple top breakout past $21.
Nice flag forming. Needs volume to move past $20.
I think the stock will need BLA news to get the volume to move past $20.
I am looking for $30-$40 by mid 2025.

FYI. Conferences this week and next week.
Perfect time to release some updates.

👍 1

Laster 3 months ago

Well yesterday sucked. Moved BACK to $20 again only to get dumped back down to $19.
Looks like it will need significant volume to move back above $20.
2 conferences in early to mid December might help.
Happy Thanksgiving.

👍️0

Laster 3 months ago

I am looking for a firm break past $20 before end of the year.
I am hopeful for continued movement early 2025.
I like stocks that hold up well during sector selloff.
JMO.

👍️0

Laster 3 months ago

Holding up well in bad biotech market right now.
Break $20 and this could get Interesting.

👍️0

Mionaer1 3 months ago

https://d1io3yog0oux5.cloudfront.net/_a2273a855b16264d98c228e2a432c4ee/capricor/news/2024-11-20_Capricor_Therapeutics_Granted_Orphan_Drug_and_301.pdf

Great news.

👍️0

Mionaer1 4 months ago

Trading range $17-22 IMO. When BLA ready (end of 2024) $30 IMO.

👍️ 1

ed3/6me 4 months ago

Thought it would've 17 so close. Only have pennies so can't buy much but figure the next level and 23/24. Down to 19/20 then bumping up past 30

👍 1

GreedyAgorist 4 months ago

Looks like you nearly nailed that floor price.

So, the first reaction to the quarterly numbers makes sense: down on still no P/E ratio (i.e., negative earnings). And then a bounce, presumably thanks to bargain hunters who think that if 20 is a bargain, then 17 is a steal.

We seem to be settling in price-wise. It's not just FOMO* up like last month, although we can, with some regularity, still get 10-15% swings either way to keep it interesting. For options traders like me, who, before the FDA/BLA news, have been buying under 5 and selling covered calls (mostly at 5, with the occasional 7.5 thrown in there) the only question is: What is the new 5? 20 or 17.50?

*with a little BTFD mixed in

👍️0

Laster 4 months ago

Excellent that $21 support held. I was nervous for a little bit.
Now let’s break $22.50 so we can have clear sailing to $30 with target $35.
I am confident (sort of) that this will occur.
Here’s hoping.

👍 1

Laster 4 months ago

Failed $22.50 break multiple times.
Probably time to consolidate before next run.
Might drop and find support at $19.50.
Hopefully not.
Still looking and hoping for volume to power this past $22.50 for good.

👍️0

Laster 4 months ago

The stock chart is showing a nice ascending triangle from Sept 30th breakout from $10.
Using my novice chart skills, I get a target of $35 for the stock (flag pole from $10 to resistance at $22.50 = $12.50).
$22.50 plus $12.50 = $35. Sounds good to me.
Lower trendline has shown nice support but if the stock moves back to $20 then stock might drop back to $17.50.
Let’s what happens this week.
Hoping for move to $25 if the market looks good.

👍️0

staynafloat 4 months ago

I think what helped the most is that the OS is only 44.7 Mil. with that added in. It appears that a lot of traders are holding making it trade very thin.

LOL ... I've been waiting for almost 5 years for this to go thru all the trials and testing and it sure is sweet :)

👍️0

GreedyAgorist 4 months ago

That dilution went about as well as any I’ve seen. The news did not even bring us below 18 for more than a wick or two. Correct me if I’m wrong, but the underwriters made out quite well, at least an extra dollar per additional share issued (~5M). Nice work if you can get it.

👍️0

Laster 4 months ago

Sounds good.
Hopefully yesterday was a technical sell off to show $20 support level.
Maybe get rid of those low hanging stop loss orders.
I am not worried about another financing so I expect a nice move to $25 then $30 by EOY.
Enjoy.

👍️0

XWAVXALMIMAN 4 months ago

No comment on Blackrock report owning over 5% of Capricor?
30 will be here soon. Maybe a short squeeze will pop us up to 40

👍️0

Laster 4 months ago

You never know but these $20 stocks tend to move to $25 or even $30.
I wouldn’t mind a nice 25% profit here.

👍️0

Volcano 4 months ago

The small float is getting locked up by big boys everyday
My prediction $30 by Thanksgiving and $50 by Christmas and $100 upon FDA approval in early next year
Thus became the millionaire stock indeed

👍️0

Mionaer1 4 months ago

Piper Sandler PT $35

Piper Sandler analyst Edward Tenthoff initiates coverage on Capricor Therapeutics (NASDAQ: $CAPR) with an Overweight rating and a price target of $35.00.

The analyst comments: "Capricor is developing deramiocel (CAP-1002) to treat cardiomyopathy in Duchenne Muscular Dystrophy (DMD) boys. In the Phase II HOPE-2 trial (N=20), deramiocel slowed LVEF decline by 107% vs. placebo at 12 months. (p=0.002) At World Muscle Society, HOPE-2 OLE data showed deramiocel achieved an 8.1 point improvement in median LVEF and 11.0ml/m2 benefit in median End Systolic Volume vs. external controls at 2 years with benefit maintained out to 3 years. Capricor has begun the rolling BLA submission, and deramiocel could gain FDA approval for DMD cardiomyopathy in 2H:25. Deramiocel is partnered globally with Nippon Shinyaku with Capricor retaining 30-50% of potential blockbuster revenues, plus up to $1.5 billion in milestones. Capricor recently issued 5.1 million shares at $17 raising gross proceeds of $86 million, bringing pro forma cash to ~ $198 million excluding 3Q:24 burn."

Mionaer1 4 months ago

$12? Never. $17 is the new floor IMO.

👍️0

ed3/6me 4 months ago

My thought is slide back to 12-15 then move to 21-25. Dip again then about 20%up. Never straight unless flooring news

👍️0

Volcano 4 months ago

This beast will keep moving up in the coming days
FDA approval is guaranteed and secured huge fund
I expect $50 by Christmas and $100 next year
I am a millionaire here

👍️0

GreedyAgorist 5 months ago

Looks like they are not even asking enough for them.

"Capricor Therapeutics (CAPR) said Thursday that it priced an underwritten offering of about 4.4 million shares at $17 per share..."

I knew the dilution was coming. I guess I was hoping that news would be later, not this week. Like the earnings report that will be a negative number (but not as negative as last quarter).

Dips are buying opportunities, but when they are based on fundamental rules of supply and demand, I wonder if there is a hurry any more. Need to know what the new plateau is. Again, I guess it was too much to ask for that to be established after this week.

: - }

👍️0

XWAVXALMIMAN 5 months ago

It looked like we would hold at 20. Then they diluted our shares. I hate when that happens. Didn’t they have enough cash to survive until we would be profitable? Hopefully good news is coming and that extra money will be used for growth

👍️0

GreedyAgorist 5 months ago

Arrgghh, they could not wait to dilute, huh? I just needed a couple more days.

Feels like somebody got the info early, too. I have to wonder what price they are getting. Today's high? The after hours' low?

👍️0

ed3/6me 5 months ago

They sell today? Would be another k in your pocket

👍️0

XWAVXALMIMAN 5 months ago

Great day today. We started out down and then reversed and had trouble getting thru 20. Since I was having eye surgery today, I put in to sell 7250 shares at 20.20. It looked good for a while when we went down to low 19’s. I tried to buy back at 18.65 but never got there. This was my 3rd time selling and buying back and selling again. I’m done. Keeping my 40.000 shares until we get to 30-40.

We ran up to 23.40 before some profit taking. Some of you are looking for a 10% correction. I use Fibonacci numbers / Elliott Wave.
We went from 4 to 22 which is 18 and then went down to around 15; a 7 point retracement. 7/18 is around 38%.

Next Wave took us from 15 to 23+. Going up 8 points means that selling should take us down 3. Expect support at 20 before the next big up move.Have a great week. Let’s Go Mets and Guardians!

👍️0

D-bol 5 months ago

DRUG We need a move like this one today!!

Yep
Still waiting for $100 Pps

👍️0

D-bol 5 months ago

Volcano are you still here? Haven’t heard from you in a while.

👍️0

GreedyAgorist 5 months ago

Just another day at the office with Capricor. Up 15%+ again. Do we get the 10% sell off before resuming the climb? That would still be a respectable gain of 7.5%. If we close above 22, that will be rarefied air for anyone in this for less than 6 years. Held the 21 handle briefly two weeks ago.

I have already played a couple of dips this week. Now waiting for a legitimate correction.

👍️0

XWAVXALMIMAN 5 months ago

Thanks Ed. I tried to sell 7250 at 19.80 which I had bought at 18.80. Still holding my 40,000 shares.
I’m buying some XRP with my profits and averaging down on some of my other losers. taking out some cash for vacations

👍️0

TechandBio 5 months ago

Next leg up will come in time patience!

$CAPR

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Capricor Therapeutics Inc (CAPR)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CAPR News

Form 8-K - Current report

Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy

Form 4 - Statement of changes in beneficial ownership of securities

Capricor Therapeutics to Participate in Upcoming Investor Conferences

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

CAPR Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Capricor Therapeutics Inc (CAPR) News

Capricor Therapeutics Inc (CAPR)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CAPR News

Form 8-K - Current report

Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy

Form 4 - Statement of changes in beneficial ownership of securities

Capricor Therapeutics to Participate in Upcoming Investor Conferences

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

CAPR Discussion

Your Recent History

Go Ad-Free